Bio-Techne Corporation
- TECH
- NASDAQ
- Biotechnology
- Life Science Reagents
- Diagnostics & Spatial Biology
$72.49
Today −0.11%Quote Oct 19, 2026, 08:00 PM UTC
+0.17%over the last month
Max drawdown −0.3%From 1-month high −0.2%3 months +1.2%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Bio-Techne
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology.
Where the money comes from
Q4 2026 revenue $321.2M
- Consumables$260.7M81.2%
- Instruments$31.5M9.8%
- Royalty$5.9M1.8%
- Other / not reported$23.1M7.2%
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
3,000
Founded
1976
Market value
$11.37B
Quote Oct 19
Floor
$72.34
0.2% below price
Resistance
$72.54
0.1% above price
Price vs analyst targets
26 analysts
Lowest target
$50.00Highest target
$73.00
$50.00Highest target
$73.00
- Price $72.49
- Average target $65.78
- Analysts' target range
The price is close to the highest analyst target. Analysts' average target sits about 9% lower.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about TECHPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free